C. P. Denton and D. Khanna, Systemic sclerosis, Lancet, vol.390, pp.1685-1699, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02042780

Y. Allanore, O. Distler, M. Matucci-cerinic, and C. P. Denton, Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis, Arthritis Rheumatol, vol.70, issue.2, pp.162-170, 2018.
DOI : 10.1002/art.40377
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40377

/. Lescoat, A. Coiffier, G. Rouil, A. Droitcourt, C. Cazalets et al., Vascular Evaluation of the Hand by Power Doppler Ultrasonography and New Predictive Markers of Ischemic Digital Ulcers in Systemic Sclerosis: Results of a Prospective Pilot Study, Arthritis Care Res, vol.69, issue.4, pp.543-551, 2017.

P. H. Carpentier, C. Biro, M. Jiguet, and H. R. Maricq, Prevalence, risk factors, and clinical correlates of ulnar artery occlusion in the general population, J Vasc Surg, vol.50, issue.6, pp.1333-1342, 2009.

P. Youssef, T. Brama, H. Englert, and J. Bertouch, Limited scleroderma is associated with increased prevalence of macrovascular disease, J Rheumatol, vol.22, issue.3, pp.469-72, 1995.

M. Hughes, A. Murray, C. P. Denton, and A. L. Herrick, Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy? Med Hypotheses, vol.116, pp.101-104, 2018.

M. Hughes, A. Tracey, M. Bhushan, K. Chakravarty, C. P. Denton et al., Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design, J Scleroderma Relat Disord, vol.3, issue.2, pp.170-174, 2018.

/. Van-den-hoogen, F. Khanna, D. Fransen, and J. , Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc, Arthritis Rheum, vol.65, issue.11, pp.2737-2784, 2013.

J. G. Coghlan, C. P. Denton, E. Grünig, D. Bonderman, O. Distler et al., DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study, Ann Rheum Dis, vol.73, issue.7, pp.1340-1349, 2014.

N. Galiè, M. Humbert, J. L. Vachiery, S. Gibbs, I. Lang et al., ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), Eur Respir J, vol.46, issue.4, pp.903-75, 2015.

M. Frerix, J. Stegbauer, D. Dragun, A. Kreuter, and S. M. Weiner, Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology (Oxford), vol.51, pp.735-777, 2012.

S. Lüders, S. Friedrich, S. Ohrndorf, A. M. Glimm, G. R. Burmester et al., Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers, Rheumatology, vol.56, issue.11, pp.1865-1873, 2017.

K. Morrisroe, W. Stevens, J. Sahhar, C. Rabusa, M. Nikpour et al., Australian Scleroderma Interest Group (ASIG). Epidemiology and disease characteristics of systemic Clinical features Sex, p.204

, Duration (Z-score, p.204

, Biology NT-proBNP a (Z-score, p.185

. Dlco, Diffusion capacity for carbon monoxide; IPDE 5, Inhibitor of phosphodiesterase type 5; IS, immunosuppressive therapy; LVEF, Left Ventricular Ejection Fraction; NT-proBNP, N-terminal probrain natriuretic peptide; NMD, no missing data; PAH, Pulmonary Arterial Hypertension

. Ssc, Systemic sclerosis; TR jet, tricuspid regurgitant jet a Natural log-transformed # All treatments are presented as "current treatment at the time of US evaluation", only steroids and IS are recorded as